Leukemia, GVHD, ATG, Transplantation Completed Phase 4 Trials for Antithymocyte immunoglobulin (rabbit) (DB00098)

IndicationStatusPhase
DBCOND0063798 (Leukemia, GVHD, ATG, Transplantation)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01856803Anti-thymocyte Globulins for Graft-versus-host Disease ProphylaxisPrevention